• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Satchmo Holdings Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
533202
INE639K01016
7.7357523
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NITESHEST
5.29
74.08
EPS(TTM)
Face Value()
Div & Yield %
0.96
10
0
 

Bacil Pharma standalone net profit rises 3000.00% in the March 2026 quarter
May 23,2026
Net profit of Bacil Pharma rose 3000.00% to Rs 0.62 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 290.00% to Rs 1.56 crore in the year ended March 2026 as against Rs 0.40 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.